MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Sex differences for off episodes in Parkinson’s disease

A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)

Meeting: 2023 International Congress

Abstract Number: 1424

Keywords: Parkinson’s, Pharmacotherapy, Wearing-off fluctuations

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: To determine the sex differences for the frequency, duration, and impact of off episodes in Parkinson’s disease (PD).

Background: Dopamine replacement therapy through oral medications provides substantial symptomatic relief in PD. However, complications of oral medications, such as the wearing off phenomenon can occur with disease progression. Women have a higher risk for wearing-off earlier in the disease course than men. Both motor and non-motor symptoms can get worse during the off episodes and these episodes can occur up to several times a day, sometimes lasting a few hours with significant impact on daily life.

Method: The data was obtained from the Fox Insight database on Feb 1st, 2023. Women and men reporting a PD diagnosis that filled out the “Impact of Off Episodes” questionnaire were included (149 women, 149 men). The questionnaire includes items on frequency, duration, and impact of off episodes over the past week. Sex differences for off episode likelihood, duration, frequency, and impact were assessed.

Results: Women and men had similar mean age and disease duration (based on early, mid, later categories). Women were less educated than men (p=.002). Majority of the sample identified as non-Hispanic (96%) and White (98%). Overall, 63% of women and 68% of men experienced off episodes (p=.39). Out of people who reported experiencing off episodes (94 women, 101 men), women experienced off episodes more frequently (p=.003), although the average and total duration of off episodes were similar for women and men. Women reported more impact of off episodes in general (p=.028). Increase in disability rate in the off episodes compared to on episodes was significantly higher for women (p=.004). Women reported experiencing more pain and more difficulty with housework or cooking than men during off (p=.010, p=.003). There were no sex differences for off episode impacts on work tasks, getting around in public, walking safely, grooming, feeling depressed or anxious, problems with concentration, memory, communication, task switching.

Conclusion: For women and men with similar age and disease duration off episode frequency and impact can differ. Women can experience more impairment during off in certain domains, and addressing and preventing fluctuations may be more important for women.

To cite this abstract in AMA style:

A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram. Sex differences for off episodes in Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/sex-differences-for-off-episodes-in-parkinsons-disease/. Accessed July 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sex-differences-for-off-episodes-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley